Skip to main content
Premium Trial:

Request an Annual Quote

Galapagos, Cellzome Forge Kinase Drug Discovery Partnership

NEW YORK (GenomeWeb News) - Galapagos and Cellzome today said that they are collaborating in kinase drug discovery. 
 
Under the terms of the agreement, Galapagos' service division BioFocus DPI will provide its SoftFocus kinase libraries to Cellzome. BioFocus will also provide biological screening and chemistry expertise to find inhibitors of Cellzome's kinase targets, the companies said.
 
The companies will use Cellzome's proprietary proteomics technology, Kinobeads, to screen the BioFocus DPI libraries in order to identify inhibitors against inflammatory kinases. 
 
As part of the service contract, BioFocus DPI will receive an upfront payment for the library access as well as research fees. Further financial details were not disclosed.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.